RK

Rakesh Kumar Annakula

Active Director Director DIN 10218083
DIN 10218083 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Rakesh Kumar Annakula

Data last updated:

Rakesh Kumar Annakula is a Director at Empower Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10218083
Primary Designation Director
Industry Pharma
First Appointment 28 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jun 20232023Active

Board colleagues of Rakesh Kumar Annakula

Directorship timeline

Open interactive timeline →
Empower Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rakesh Kumar Annakula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Kumar Annakula

Rakesh Kumar Annakula currently holds 1 directorship: Empower Pharmaceuticals Private Limited (Director, since 28 Jun 2023).

Rakesh Kumar Annakula was first appointed on 28 Jun 2023 as Director at Empower Pharmaceuticals Private Limited.

The current boards of Rakesh Kumar Annakula's companies include Ashok Mittapelly (Empower Pharmaceuticals Private Limited), Mahendar Papunuka (Empower Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available